Archive · 18 Aug 2025
Sudarshan Pharma Stock Jumps on Q1 Results, Acquisition
A small pharmaceutical company called Sudarshan Pharma saw its stock price go up after they announced how much money they made in the first three months of the year.
They made a profit, but a bit less than the previous quarter.
They made a lot more money compared to last year.
The company is also buying a new plant to make more products, which means they might be growing.
Sudarshan Pharma Industries' stock rose over 4% after Q1 results.
Net profit for the quarter ending June 2025 was ₹3.74 crore.
Revenue from operations jumped nearly 40% to ₹142.31 crore.
The company is acquiring land and assets from Srigen Lifesciences.
The acquisition will strengthen Sudarshan Pharma Industries' production capacity.
- Who
- Sudarshan Pharma Industries
- What
- Sudarshan Pharma Industries' stock increased due to Q1 results and acquisition updates.
- When
- The stock increased on Monday, August 18.
- Where
- BSE (Bombay Stock Exchange).
- Why
- Due to strong quarterly results and an acquisition to increase production capacity.
- Stock Increase
- 4%
- Opening Price
- ₹31.50
- Net Profit Q1FY26
- ₹3.74 crore
- Revenue Q1FY26
- ₹142.31 crore
- Revenue YoY Growth
- 40%
- Acquisition
- Land and assets from Srigen Lifesciences
- Acquisition Consideration
- ₹25.50 crore
